Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCAS4 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
mRNA | PPP2R3B | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
mRNA | ERGIC1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
mRNA | IL15 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
mRNA | COPE | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
mRNA | RAPGEF5 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
mRNA | NAGLU | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
mRNA | PHF8 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
mRNA | TMIGD2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
mRNA | PTPRM | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |